AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment EP News Bureau Aug 4, 2020 I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…
Doctors view ‘antiviral agents’ as the most effective therapeutic option for treating COVID-19:… EP News Bureau Jul 8, 2020 Anti-inflammatory drugs, convalescent plasma therapy are opined to be the next-best treatments; AI, ML, Big Data and IoT emerge as…
Anti-inflammatory and cancer drugs tested in UK as possible COVID-19 therapy Reuters Jun 11, 2020 Izana Bioscience's Namilumab, a monoclonal antibody already in late-stage tests to treat rheumatoid arthritis and an inflammatory…
